Sales of contact lenses increased by 22 percent to $51.2 million in the second quarter for Valeant Pharmaceuticals, the parent company of Bausch & Lomb. They were up by 19 percent in the first six months of this year, driven by BioTrue, which has been launched also in China. Valeant's ...
Buying a membership today will give you:
To continue reading this article register now.